Doctor profile · Federal record

Dr. Neeraja Mattay, M.D.

Specialist (CMS: Dermatology) · Centreville, VA

  • NPI 1891721502
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 38 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
13880 Braddock RD, 301
Centreville, VA 201212459
(703) 222-2773
fax (703) 222-6093
Mailing address
1424 Woodhurst Blvd
Mc Lean, VA 221022233

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
November 20, 2007
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
174400000X — NUCC code
State license (1)
Virginia #0101047432

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1891721502. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,746
Distinct HCPCS
10
Medicare allowed
$120,262
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 549 119 $8
99213 Established patient office or other outpatient visit, 20-29 minutes 376 337 $100
17000 Destruction of precancer skin growth, 1 growth 212 187 $63
99214 Established patient office or other outpatient visit, 30-39 minutes 123 100 $140
11102 Biopsy of related skin growth, first growth 117 109 $108
17110 Destruction of skin growth, 1-14 growths 102 95 $130
99212 Established patient office or other outpatient visit, 10-19 minutes 73 71 $63
99203 New patient office or other outpatient visit, 30-44 minutes 66 66 $122
11103 Biopsy of related skin growth, each additional growth 30 22 $58
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 30 14 $1

In context: peer comparison

Among 1 peers in this city , average services per provider: 124. This provider delivers 14× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,566
Transactions
70
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 13 $253.86
Lilly USA, LLC 10 $204.00
E.R. Squibb & Sons, L.L.C. 8 $162.38
Arcutis Biotherapeutics, Inc. 10 $147.72
Dermavant Sciences, Inc. 7 $143.68
Janssen Biotech, Inc. 2 $99.09
Amgen Inc. 4 $94.91
Regeneron Healthcare Solutions, Inc. 3 $76.54
Incyte Corporation 3 $74.76
Novartis Pharmaceuticals Corporation 2 $63.39
Boehringer Ingelheim Pharmaceuticals, Inc. 2 $52.21
PFIZER INC. 2 $36.90
Galderma Laboratories, L.P. 2 $36.32
GENZYME CORPORATION 1 $32.58
Verrica Pharmaceuticals Inc. 1 $24.49

By nature of payment

Food and Beverage
$1,486
Education
$80

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
261
Patients
128
Total drug cost
$92,595
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 41 28 $1,988
Triamcinolone Acetonide Generic 36 29 $563
Ketoconazole Generic 22 0 $487
Metronidazole Generic 22 17 $1,615
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 20 12 $1,192
Desonide Generic 19 14 $693
Valacyclovir (Valacyclovir Hcl) Brand 17 0 $260
Mupirocin Generic 16 14 $142
Fluorouracil Generic 15 14 $1,301
Minoxidil Generic 15 0 $240

Frequently asked questions

Auto-generated from federal data
What is Dr. Neeraja Mattay's medical specialty?
Dr. Neeraja Mattay practices Specialist in Centreville, VA.
Where does Dr. Neeraja Mattay practice?
Dr. Neeraja Mattay practices at 13880 Braddock RD, Centreville, VA 201212459. Office phone: 7032222773.
What is Dr. Neeraja Mattay's NPI?
Dr. Neeraja Mattay's National Provider Identifier (NPI) is 1891721502, issued by NPPES.
Does Dr. Neeraja Mattay accept Medicare assignment?
Yes. Dr. Neeraja Mattay accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Neeraja Mattay commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.